Lupin introduces Honeywell Solstice Air inhalers for sustainable respiratory care
Thursday, 22 May 2025
Lupin is now utilizing Honeywell’s Solstice Air in its respiratory inhalers, significantly improving respiratory care with propellants that have near-zero global warming potential. This advancement, designed for asthma and COPD patients, reduces greenhouse gas emissions by up to 99.9% compared to traditional HFC-based propellants, marking a substantial stride in decreasing carbon emissions.
|
||||
|
|
||||
You Might Like |
||||
